China to decide whether to hide WHO vaccination program through Trump


China faces a major test in its vaccine diplomacy, with its deadline approaching as to whether it will formally join a global health organization-sponsored effort to ensure Everybody around the world has been’ vaccinated against COVID 19.

China to decide whether to hide WHO vaccination program through Trump


Friday is the final day for governments to decide whether to participate in COVAX, a $ 18 billion initiative that seeks to give low-income countries access to vaccines like rich countries. Beijing has said it will "help" Kovacs without explicitly stating that it is investing in the project. The verified list of participants will be published’ on Monday, September 21, according to the World Health Organization.

Signing up will help improve China's image around the world of how it handled the initial epidemic in Wuhan, especially since the Trump administration refused to join the Caucasus. So far, Beijing has focused on cutting one-to-one contracts for vaccine doses with friendly governments as the United States moves away from the United States to Chinese companies for 5G networks, computer chips and large infrastructure projects. Has appealed.

“Beijing is facing criticism from the West over the launch of Covid 19 in Wuhan, and China's transparency in the early days of the virus's spread," said Eurasia Group analyst Kelsey Broderick. "Joining a popular initiative like Kovacs will definitely help change the perception that China is a bad actor."

President Xi Jinping promised in May that the vaccine developed by China would be a global "public good" that everyone could share. However, China has not made it clear whether it will sign, but Foreign Ministry spokeswoman Hua Chunying said this month that China's actions were "similar to those of the Caucasus."

CovAX, also led by the Alliance's Infectious Diseases Preparatory Innovations and Vaccine Alliance Gavi, to give governments a chance to curb the risk of backing failed vaccine candidates and give LDCs access to shots. Which would otherwise be unbearable. It has nine vaccines in development and is under re-evaluation in its portfolio. The goal is to save 2 billion doses by 2021.

Self-financing countries can pay a front fee for the amount of the vaccine, which can be up to 50% of their population, although the shots will be’ distributed to the relatively poor and rich countries as soon as they become available. Governments that sign up are free to reach bilateral agreements to secure supplies separately.

It would be a big deal for Kovacs to ship to China, which had discussed about 172 countries to participate by August 24. The possibility of feeding even a fraction of China's 1.4 billion people will boost the alliance, which will boost alliance talks. power

For China, Kovacs can serve as a kind of insurance policy that gives it access to any successfully developed vaccine. While being a member does not necessarily mean that Chinese vaccines will be included in the Caucasus portfolio, it is possible that this is the case. China can also provide manufacturing support for a successful vaccine, regardless of which country it develops.

Participation could mean that Chinese vaccine makers play a key role in the global rollout. And if China's advanced vaccines were chosen’ their brands would benefit from WHO certification, according to Xiao Kong Lu Boynton, an adviser to the Albright Stonebridge Group, which specializes in healthcare and life sciences. Focus

"It will be a huge boost for Beijing, both industrially and politically," he said.

Diplomatic angle
China does not have much experience in developing and distributing vaccines for global consumption. The industry's reputation was tarnished’ in 2018 when two Chinese vaccine makers were found to be cutting corners in production, hurting trust at home and abroad.

Nevertheless, China has been at the forefront of developing vaccines against the corona virus. Nine Chinese vaccine candidates have entered clinical trials, and four of them have received approval for the final phase III clinical trials in foreign countries.

The Tianjin-based casino was the first in the world to reach the final stages of human testing for a vaccine developed in collaboration with the Chinese military. CanSino Biologics, Sinovac Biotech Limited and China National Biotech Group have started testing in countries including Brazil, Russia, Indonesia, UAE, Peru, Chile and Morocco.

The vaccine could help make Beijing a lost diplomatic arena, as China faces threats to Taiwan, as well as human rights abuses in Hong Kong and Xinjiang. China has pledged to prioritize food supplies to at least 62 countries, including governments that have received infrastructure loans under the Food Belt and Road Initiative. Indonesia, Bangladesh, Pakistan and Morocco have formal agreements with major Chinese vaccine manufacturers, and Egypt is close to signing them.

"Both the Chinese government and state-owned enterprises want to protect their infrastructure projects, as well as the personnel on the ground, if the epidemic situation in these countries improves," said Yuji, a senior Chinese research fellow at think tank Chatham House. If so, it will also help China.

Latin American and Caribbean countries have been promised’ a $1 billion loan to buy Chinese-designed vaccines. Currently, Mexico, Chile, Brazil, and Argentina have all pledged to test the Chinese vaccine. The region has been’ hit hardest by the deaths of Brazil, Mexico and Peruvian, among the top 10 countries in the world.

Trusting China
Yoshikazu Kato, an associate professor at the Asia Global Institute at the University of Hong Kong, said Xi, who specializes in Chinese diplomacy, lacked global confidence in China due to Xi's aggressive foreign policy. Has cast doubt on the conduct and intentions of .

"Under these circumstances, how can countries trust China?" They said.

An incident involving Ken Sino and Canada allayed fears that China could use its vaccine for political purposes. According to the National Research Council of Canada, the Chinese company was to send its vaccine candidate to begin clinical trials in Canada, but Chinese customs did not approve the shipment.

Malaysia is in talks with several parties, including China. "We have more questions than answers at the moment," said Noor Hisham Abdullah, the Southeast Asian country's director general of health. Had agreed to buy millions of doses, and is expected’ to be ready by the end of next year.

Not everyone is related. The Philippines, which has agreed to accept the vaccine from the United States, Russia and China, has rejected the notion that China is using the vaccine for diplomatic purposes. "China has no concerns about vaccines," said Theodore Locsin, Philippine foreign secretary.

"I think it's in China's interest to join China," said Wang Huiyao, a Chinese cabinet adviser and founder of the Center for China and Globalization. If the world is still plagued’ by epidemics, China will not be in a better position.


READ MORE 

Trump says Coronavirus is good because he did not shake hands with 'disgusting people', claims former White House aide